|

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

RECRUITINGSponsored by University of Louisville
Actively Recruiting
SponsorUniversity of Louisville
Started2016-01
Est. completion2030-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations11 sites
View on ClinicalTrials.gov →

NCT02674100

Summary

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (greater than 18 years of age) diagnosed with pancreatic cancer that are eligible for soft tissue ablation per the treating physician.

Exclusion Criteria:

* Have a cardiac pacemaker or ICD implant
* Non-removable implants with metal parts near target lesion
* Myocardial infarction within 3 months prior to enrollment
* Not suitable for general endotracheal anesthesia

Conditions2

CancerPancreatic Cancer

Locations11 sites

University of Alabama Birmingham
Birmingham, Alabama, 35233
John Christein, MDjchristein@uabmc.edu
University of California San Diego
San Diego, California, 92093
Rebekah White, MDreqhite@ucsd.edu
University of Colorado
Denver, Colorado, 80309
Ana Gleisnerana.gleisner@ucdenver.edu
University of South Florida
Tampa, Florida, 33620
Rachel Karlnoskirkarlnos@health.usf.edu
Augusta University
Augusta, Georgia, 30912
Edward Kruse, MDekruse@gru.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.